The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Reduction of Nightmares and Other PTSD Symptoms in Combat Veterans by Prazosin: A Placebo-Controlled Study
Abstract
OBJECTIVE: Prazosin is a centrally active alpha(1) adrenergic antagonist. The authors' goal was to evaluate prazosin efficacy for nightmares, sleep disturbance, and overall posttraumatic stress disorder (PTSD) in combat veterans. METHOD: Ten Vietnam combat veterans with chronic PTSD and severe trauma-related nightmares each received prazosin and placebo in a 20-week double-blind crossover protocol. RESULTS: Prazosin (mean dose=9.5 mg/day at bedtime, SD=0.5) was superior to placebo for the three primary outcome measures: scores on the 1) recurrent distressing dreams item and the 2) difficulty falling/staying asleep item of the Clinician-Administered PTSD Scale and 3) change in overall PTSD severity and functional status according to the Clinical Global Impression of change. Total score and symptom cluster scores for reexperiencing, avoidance/numbing, and hyperarousal on the Clinician-Administered PTSD Scale also were significantly more improved in the prazosin condition, and prazosin was well tolerated. CONCLUSIONS: These data support the efficacy of prazosin for nightmares, sleep disturbance, and other PTSD symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The development of a Clinician-Administered PTSD Scale
Blake, D. D., Weathers, F. W., Nagy, L. M., Kaloupek, D. G., Gusman, F. D., Charney, D. S., & Keane, T. M. (1995) · Journal of Traumatic Stress · doi:10.1002/jts.2490080106 · Cited by 5,024
Arky, R. A. (1994) · Cited by 2,632
Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.5.624 · Cited by 721
CSF Norepinephrine Concentrations in Posttraumatic Stress Disorder
Geracioti, T. D., Baker, D. G., Ekhator, N. N., West, S. A., Hill, K. K., Bruce, A. B., Schmidt, D., Rounds-Kugler, B., Yehuda, R., Keck, P. E., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1227 · Cited by 462
α-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function
Arnsten, A. F. T., Mathew, R., Ubriani, R., Taylor, J. R., & Li, B.-M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00296-0 · Cited by 245
Woodward, S. H., Arsenault, N. J., Murray, C. F., & Bliwise, D. L. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00917-3 · Cited by 163
Taylor, F., & Raskind, M. A. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00013 · Cited by 161
Self-citationRaskind, M. A., Dobie, D. J., Kanter, E. D., Petrie, E. C., Thompson, C. E., & Peskind, E. R. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0208 · Cited by 154
Self-citationPrazosin Reduces Nightmares in Combat Veterans With Posttraumatic Stress Disorder
Raskind, M. A., Thompson, C. E., Petrie, E. C., Dobie, D. J., Rein, R. J., Hoff, D. J., McFall, M., & Peskind, E. R. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0705 · Cited by 146
Self-citationVythilingam, M., Anderson, G. M., Owens, M. J., Halaszynski, T. M., Bremner, J. D., Carpenter, L. L., Heninger, G. R., Nemeroff, C. B., & Ds, C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.11.4138 · Cited by 52
Cited by
Stress signalling pathways that impair prefrontal cortex structure and function
Arnsten, A. F. T. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2648 · Cited by 3,299
Control of sleep and wakefulness
Brown, R. E., Basheer, R., McKenna, J. T., Strecker, R. E., & McCarley, R. W. (2012) · Physiological Reviews · doi:10.1152/physrev.00032.2011 · Cited by 1,477
The sleep-deprived human brain
Krause, A. J., Simon, E. B., Mander, B. A., Greer, S. M., Saletin, J. M., Goldstein-Piekarski, A. N., & Walker, M. P. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.55 · Cited by 1,200
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
The role of sleep in emotional brain function
Goldstein, A. N., & Walker, M. P. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153716 · Cited by 1,052
“Given nocturnally, patients with combat PTSD and civilian PTSD both demonstrate a restoration of REM sleep, together with decreases in trauma-dream symptomatology (Calohan et al 2010, Raskind et al 2007, Raskind et al 2003, Taylor et al 2008).”
BackgroundNeurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions
Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.019 · Cited by 948
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Response Variation following Trauma: A Translational Neuroscience Approach to Understanding PTSD
Yehuda, R., & LeDoux, J. (2007) · Neuron · doi:10.1016/j.neuron.2007.09.006 · Cited by 783
Morin, C. M., Drake, C. L., Harvey, A. G., Krystal, A. D., Manber, R., Riemann, D., & Spiegelhalder, K. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.26 · Cited by 746
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
“…studies provide evidence for the efficacy of the alpha-adrenergic agonist prazosin in reducing nightmares and other PSTD symptoms [I (PCT)] (Raskind et al., 2003), for olanzapine in reducing post-traumatic and depressive symptoms and sleep disturbance [I (PCT)] (Stein et al., 2002b) and…”
BackgroundAdrenergic pharmacology and cognition: Focus on the prefrontal cortex
Ramos, B. P., & Arnsten, A. F. T. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.11.006 · Cited by 641
Sleep disturbances as the hallmark of PTSD: where are we now?
Germain, A. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12040432 · Cited by 634
The long-term costs of traumatic stress: intertwined physical and psychological consequences
McFARLANE, A. C. (2010) · World Psychiatry · doi:10.1002/j.2051-5545.2010.tb00254.x · Cited by 607
Raskind, M. A., Peskind, E. R., Hoff, D. J., Hart, K. L., Holmes, H. A., Warren, D., Shofer, J., O’Connell, J., Taylor, F., Gross, C., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.032 · Cited by 552
Self-citationBrain mechanisms of insomnia: new perspectives on causes and consequences
Van Someren, E. J. W. (2021) · Physiological Reviews · doi:10.1152/physrev.00046.2019 · Cited by 543
Disturbed sleep in post-traumatic stress disorder: secondary symptom or core feature?
Spoormaker, V. I., & Montgomery, P. (2008) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2007.08.008 · Cited by 527
Pharmacotherapy for post traumatic stress disorder (PTSD)
Stein, D. J., Ipser, J. C., Seedat, S., Sager, C., & Amos, T. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002795.pub2 · Cited by 519
Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks
Arnsten, A. F. T. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.027 · Cited by 493
Stimulants: Therapeutic Actions in ADHD
Arnsten, A. F. T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301164 · Cited by 473
“Based on this work, the a1 receptor blocker, prazosin, is now in use for the treatment of post-traumatic stress disorder (Raskind et al, 2003).”
BackgroundPosttraumatic Stress Disorder in Adults: Impact, Comorbidity, Risk Factors, and Treatment
Sareen, J. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900902 · Cited by 467
Benedek, D. M., Fullerton, C., & Ursano, R. J. (2007) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.28.021406.144037 · Cited by 462
Germain, A., Buysse, D. J., & Nofzinger, E. (2008) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2007.09.003 · Cited by 421
Lee, D. J., Schnitzlein, C. W., Wolf, J. P., Vythilingam, M., Rasmusson, A. M., & Hoge, C. W. (2016) · Depression and Anxiety · doi:10.1002/da.22511 · Cited by 416
A Distinct Role for Norepinephrine in Memory Retrieval
Murchison, C. F., Zhang, X.-Y., Zhang, W.-P., Ouyang, M., Lee, A., & Thomas, S. A. (2004) · Cell · doi:10.1016/s0092-8674(04)00259-4 · Cited by 402
Psychiatric Disorders and Sleep
Krystal, A. D. (2012) · Neurologic Clinics · doi:10.1016/j.ncl.2012.08.018 · Cited by 386
REM sleep depotentiates amygdala activity to previous emotional experiences
van der Helm, E., Yao, J., Dutt, S., Rao, V., Saletin, J. M., & Walker, M. P. (2011) · Current Biology · doi:10.1016/j.cub.2011.10.052 · Cited by 379
“Indeed, the current findings offer a putative neurobiological explanation for the recent pharmacological treatment success involving nighttime suppression of adrenergic activity in PTSD, restoring REM sleep features and improving clinical symptomatology [12, 44, 45].”
Arnsten, A. F. T., Raskind, M. A., Taylor, F. B., & Connor, D. F. (2015) · Neurobiology of Stress · doi:10.1016/j.ynstr.2014.10.002 · Cited by 381
Self-citationGuidelines for Treating Dissociative Identity Disorder in Adults, Third Revision
International Society for the Study of Trauma and Dissociati (2011) · Journal of Trauma & Dissociation · doi:10.1080/15299732.2011.537247 · Cited by 374
Posttraumatic Stress Disorder: Etiology, Epidemiology, and Treatment Outcome
Keane, T. M., Marshall, A. D., & Taft, C. T. (2006) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.2.022305.095305 · Cited by 366
Raskind, M. A., Peterson, K., Williams, T., Hoff, D. J., Hart, K., Holmes, H., Homas, D., Hill, J., Daniels, C., Calohan, J., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12081133 · Cited by 355
Self-citationPharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review
Berger, W., Mendlowicz, M. V., Marques-Portella, C., Kinrys, G., Fontenelle, L. F., Marmar, C. R., & Figueira, I. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.12.004 · Cited by 347
Trial of prazosin for post-traumatic stress disorder in military veterans
Raskind, M. A., Peskind, E. R., Chow, B., Harris, C., Davis-Karim, A., Holmes, H. A., Hart, K. L., McFall, M., Mellman, T. A., Reist, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1507598 · Cited by 342
Self-citationBest practice guide for the treatment of nightmare disorder in adults
Standards of Practice Committee, Aurora, R. N., Zak, R. S., Auerbach, S. H., Casey, K. R., Chowdhuri, S., Karippot, A., Maganti, R. K., Ramar, K., Kristo, D. A., et al. (2010) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27883 · Cited by 341
Taylor, F. B., Martin, P., Thompson, C., Williams, J., Mellman, T. A., Gross, C., Peskind, E. R., & Raskind, M. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.07.001 · Cited by 336
Self-citationMaher, M. J., Rego, S. A., & Asnis, G. M. (2006) · CNS Drugs · doi:10.2165/00023210-200620070-00003 · Cited by 334
Current perspectives of the roles of the central norepinephrine system in anxiety and depression
Goddard, A. W., Ball, S. G., Martinez, J., Robinson, M. J., Yang, C. R., Russell, J. M., & Shekhar, A. (2010) · Depression and Anxiety · doi:10.1002/da.20642 · Cited by 316
Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder
Strawn, J. R., & Geracioti, T. D. (2008) · Depression and Anxiety · doi:10.1002/da.20292 · Cited by 310
Arnsten, A. F., Scahill, L., & Findling, R. L. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.0098 · Cited by 307
Cognitive emotion regulation fails the stress test
Raio, C. M., Orederu, T. A., Palazzolo, L., Shurick, A. A., & Phelps, E. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305706110 · Cited by 302
Talbot, L. S., Maguen, S., Metzler, T. J., Schmitz, M., McCaslin, S. E., Richards, A., Perlis, M. L., Posner, D. A., Weiss, B., Ruoff, L., et al. (2014) · Sleep · doi:10.5665/sleep.3408 · Cited by 294
Treatment of Nightmares With Prazosin: A Systematic Review
Kung, S., Espinel, Z., & Lapid, M. I. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.05.015 · Cited by 277
Krystal, J. H., Davis, L. L., Neylan, T. C., A. Raskind, M., Schnurr, P. P., Stein, M. B., Vessicchio, J., Shiner, B., Gleason, T. D., & Huang, G. D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.03.007 · Cited by 265
“Additionally, prazosin has been found to be particularly helpful for insomnia and nightmares associated with PTSD (51-53) and showed significant efficacy in patients with greater than average baseline standing systolic blood pressure, a potential sign of noradrenergic activation, but its efficacy”
BackgroundBrennan, A. R., & Arnsten, A. F. T. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1417.007 · Cited by 267
McLean, L. M., & Gallop, R. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.369 · Cited by 262
Morgenthaler, T. I., Auerbach, S., Casey, K. R., Kristo, D., Maganti, R., Ramar, K., Zak, R., & Kartje, R. (2018) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7178 · Cited by 230
Relationships between REM sleep findings and PTSD symptoms during the early aftermath of trauma
Mellman, T. A., Pigeon, W. R., Nowell, P. D., & Nolan, B. (2007) · Journal of Traumatic Stress · doi:10.1002/jts.20246 · Cited by 221
Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD)
Ipser, J. C., & Stein, D. J. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001209 · Cited by 216
PTSD and stress sensitisation: A tale of brain and body
Stam, R. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.11.010 · Cited by 211
Mellman, T. A. (2008) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2008.01.010 · Cited by 204
Arnsten, A. F. T. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm033 · Cited by 200
Dissemination of CBTI to the Non-Sleep Specialist: Protocol Development and Training Issues
Manber, R., Carney, C., Edinger, J., Epstein, D., Friedman, L., Haynes, P. L., Karlin, B. E., Pigeon, W., Siebern, A. T., & Trockel, M. (2012) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.1786 · Cited by 178
Mellman, T. A. (2006) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.08.005 · Cited by 165
Heart rate variability during sleep and the early development of posttraumatic stress disorder
Mellman, T. A., Knorr, B. R., Pigeon, W. R., Leiter, J. C., & Akay, M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.018 · Cited by 155
Pharmacotherapy of PTSD: premises, principles, and priorities.
Ravindran, L. N., & Stein, M. B. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.037 · Cited by 153
The beta-1 adrenergic antagonist, betaxolol, improves working memory performance in rats and monkeys
Ramos, B. P., Colgan, L., Nou, E., Ovadia, S., Wilson, S. R., & Arnsten, A. F. T. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.022 · Cited by 147
Revisiting propranolol and PTSD: Memory erasure or extinction enhancement?
Giustino, T. F., Fitzgerald, P. J., & Maren, S. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.01.009 · Cited by 137
Hains, A. B., & Arnsten, A. F. T. (2008) · Learning & Memory · doi:10.1101/lm.921708 · Cited by 127
“Prazosin improves symptoms of intrusive re-experiencing of the trauma and reduces psychological distress in response to trauma related cues (Raskind et al. 2003; Taylor et al. 2006; Strawn and Geracioti Jr. 2007).”
BackgroundHoskins, M. D., Bridges, J., Sinnerton, R., Nakamura, A., Underwood, J. F. G., Slater, A., Lee, M. R. D., Clarke, L., Lewis, C., Roberts, N. P., et al. (2021) · European Journal of Psychotraumatology · doi:10.1080/20008198.2020.1802920 · Cited by 127
Sleep disturbances in the aftermath of trauma and posttraumatic stress disorder
Mellman, T. A., & Hipolito, M. M. S. (2006) · CNS Spectrums · doi:10.1017/s1092852900013663 · Cited by 115
Complex Trauma in Adolescents and Adults
Briere, J., & Scott, C. (2015) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.05.004 · Cited by 114
Sleep Disturbance in Pediatric PTSD: Current Findings and Future Directions
Kovachy, B., O’Hara, R., Hawkins, N., Gershon, A., Primeau, M. M., Madej, J., & Carrion, V. (2013) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.2678 · Cited by 109
Clinical correlates of poor sleep quality in posttraumatic stress disorder
Germain, A., Buysse, D. J., Shear, M. K., Fayyad, R., & Austin, C. (2004) · Journal of Traumatic Stress · doi:10.1007/s10960-004-5796-6 · Cited by 107
Cates, M. E., Bishop, M. H., Davis, L. L., Lowe, J. S., & Woolley, T. W. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1e043 · Cited by 105
Psychostimulants and motivated behavior: Arousal and cognition
Berridge, C. W., & Arnsten, A. F. T. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.11.005 · Cited by 104
Geracioti, T. D., Baker, D. G., Kasckow, J. W., Strawn, J. R., Jeffrey Mulchahey, J., Dashevsky, B. A., Horn, P. S., & Ekhator, N. N. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.12.012 · Cited by 103
Augedal, A. W., Hansen, K. S., Kronhaug, C. R., Harvey, A. G., & Pallesen, S. (2013) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2012.06.001 · Cited by 98
The neurobiology of the stress-resistant brain
Fleshner, M., Maier, S. F., Lyons, D. M., & Raskind, M. A. (2011) · Stress · doi:10.3109/10253890.2011.596865 · Cited by 98
Self-citationSleep disturbances and PTSD: a perpetual circle?
van Liempt, S. (2012) · European Journal of Psychotraumatology · doi:10.3402/ejpt.v3i0.19142 · Cited by 93
Agorastos, A., Boel, J. A., Heppner, P. S., Hager, T., Moeller-Bertram, T., Haji, U., Motazedi, A., Yanagi, M. A., Baker, D. G., & Stiedl, O. (2013) · Stress · doi:10.3109/10253890.2012.751369 · Cited by 88
Kampman, M., Keijsers, G. P. J., Hoogduin, C. A. L., & Hendriks, G.-J. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0904 · Cited by 87
Sleep in PTSD: Treatment approaches and outcomes
Miller, K. E., Brownlow, J. A., & Gehrman, P. R. (2020) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2019.08.017 · Cited by 87
Yücel, D. E., van Emmerik, A. A. P., Souama, C., & Lancee, J. (2020) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2019.101248 · Cited by 85
Molecular Influences on Working Memory Circuits in Dorsolateral Prefrontal Cortex
Arnsten, A. F. T., & Jin, L. E. (2014) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-420170-5.00008-8 · Cited by 77
Novel treatment approaches for refractory anxiety disorders
Pollack, M. H., Otto, M. W., Roy-Byrne, P. P., Coplan, J. D., Rothbaum, B. O., Simon, N. M., & Gorman, J. M. (2008) · Depression and Anxiety · doi:10.1002/da.20329 · Cited by 77
Bajor, L. A., Ticlea, A. N., & Osser, D. N. (2011) · Harvard Review of Psychiatry · doi:10.3109/10673229.2011.614483 · Cited by 76
Traumatic Brain Injury and Posttraumatic Stress Disorder
Bahraini, N. H., Breshears, R. E., Hernández, T. D., Schneider, A. L., Forster, J. E., & Brenner, L. A. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2013.11.002 · Cited by 70
Woodward, S. H., Arsenault, N. J., Voelker, K., Nguyen, T., Lynch, J., Skultety, K., Mozer, E., Leskin, G. A., & Sheikh, J. I. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.005 · Cited by 61
Prazosin for treatment of post-traumatic stress disorder: a systematic review and meta-analysis
Reist, C., Streja, E., Tang, C. C., Shapiro, B., Mintz, J., & Hollifield, M. (2021) · CNS Spectrums · doi:10.1017/s1092852920001121 · Cited by 56
Tailoring therapeutic strategies for treating posttraumatic stress disorder symptom clusters
Norrholm, S., & Jovanovic, T. (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s10951 · Cited by 56
Treatment of posttraumatic stress disorder: Focus on pharmacotherapy
Ehret, M. (2019) · Mental Health Clinician · doi:10.9740/mhc.2019.11.373 · Cited by 53
Kobori, N., Hu, B., & Dash, P. K. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.10.048 · Cited by 53
Arnsten, A. F. T., & Wang, M. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103617 · Cited by 50
Simor, P., Horváth, K., Ujma, P. P., Gombos, F., & Bódizs, R. (2013) · Biological Psychology · doi:10.1016/j.biopsycho.2013.05.022 · Cited by 48
Szeleszczuk, Ł., & Frączkowski, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710099 · Cited by 46
Noradrenergic α1-Adrenoceptor Actions in the Primate Dorsolateral Prefrontal Cortex
Datta, D., Yang, S.-T., Galvin, V. C., Solder, J., Luo, F., Morozov, Y. M., Arellano, J., Duque, A., Rakic, P., Arnsten, A. F. T., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2472-18.2019 · Cited by 44
Bajor, L. A., Balsara, C., & Osser, D. N. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114840 · Cited by 43
Barton, S., Karner, C., Salih, F., Baldwin, D. S., & Edwards, S. J. (2014) · Health Technology Assessment · doi:10.3310/hta18500 · Cited by 36
Agorastos, A., Kellner, M., Baker, D. G., & Otte, C. (2014) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000079 · Cited by 33
VAN LIEMPT, S., VERMETTEN, E., GEUZE, E., & WESTENBERG, H. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1364.053 · Cited by 29
A 2023 update on the advancements in the treatment of agitation in Alzheimer’s disease
Lee, D., Clark, E. D., Antonsdottir, I. M., & Porsteinsson, A. P. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2195539 · Cited by 28
Treating complicated grief: effects on sleep quality
Germain, A., Shear, K., Monk, T. H., Houck, P. R., Reynolds, III, Frank, E., & Buysse, D. J. (2006) · Behavioral Sleep Medicine · doi:10.1207/s15402010bsm0403_2 · Cited by 20
Rhudy, J. L., Davis, J. L., Williams, A. E., McCabe, K. M., & Byrd, P. M. (2008) · Behavioral Sleep Medicine · doi:10.1080/15402000802162539 · Cited by 19
Psychopharmacologic Treatments for Dissociative Identity Disorder
Loewenstein, R. J. (2005) · Psychiatric Annals · doi:10.3928/00485713-20050801-08 · Cited by 16
Plante, D. T., & Winkelman, J. W. (2006) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.08.006 · Cited by 16
Advances in the management of treatment-resistant anxiety disorders
Lanouette, N. M., & Stein, M. B. (2010) · Focus · doi:10.1176/foc.8.4.foc501 · Cited by 15
Metadata
- Authors
- Raskind, M. A., Peskind, E. R., Kanter, E. D., Petrie, E. C., Radant, A., Thompson, C. E., Dobie, D. J., Hoff, D., Rein, R. J., Straits-Tröster, K., Thomas, R. G., & McFall, M. M.
- Venue
- American Journal of Psychiatry
- Published
- 2003-02-01
- Volume
- 160
- Issue
- 2
- Pages
- 371-373
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2170933900
- Cited by
- 607
- References
- 11
- FWCI
- 28.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.